Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enpath Medical Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enpath Medical Inc since year 2005.
Table 2 shows the detailed insider transactions of Enpath Medical Inc since 2005.
The reporting company's ticker symbol is NPTH. The reporting company's CIK number is 833140.
The total value of stock buying since 2005 is $181,986.
The total value of stock sales since 2005 is $388,756.
The total value of stock option exercises since 2005 is $337,421.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2007-02-28||Kraus Mark C (Vice President & General Mgr)||Sale||8,275||11.23||92,928|
|2007-02-26||Kraus Mark C (Vice President & General Mgr)||Sale||6,100||11.21||68,362|
|2007-02-01||Kraus Mark C (Vice President & General Mgr)||Option Ex||10,000||4.62||46,250|
|2007-01-31||Hartman James D (Director)||Option Ex||15,000||4.62||69,375|
|2007-01-24||Erdmann Michael (Secretary)||Option Ex||5,000||4.62||23,125|
|2006-11-24||Kraus Mark C (VP & GM Introducer Bus. Unit)||Sale||840||11.34||9,525|
|2006-11-13||Erdmann Michael (Secretary)||Sale||4,000||10.45||41,800|
|2006-08-31||Hartman James D (Director)||Sale||2,000||9.90||19,800|
|2006-06-12||Kraus Mark C (VP & GM Introducer Bus. Unit)||Option Ex||20,000||2.62||52,500|
|2006-05-26||Erdmann Michael (Secretary)||Sale||761||10.65||8,104|
|2006-05-25||Erdmann Michael (Secretary)||Sale||402||10.65||4,281|
|2006-05-25||Kraus Mark C (VP & GM Introducer Bus. Unit)||Sale||6,900||10.61||73,209|
|2006-04-20||Auth Thomas L (Director)||Option Ex||15,000||1.66||24,840|
|2006-03-08||Mellor James E (VP Sales & Marketing)||Sale||2,354||9.51||22,386|
|2006-03-01||Erdmann Michael (Secretary)||Sale||4,000||8.98||35,920|
|2006-02-28||Kraus Mark C (VP & GM Introducer Bus. Unit)||Sale||3,900||3.19||12,441|
|2006-02-02||Erdmann Michael (Secretary)||Option Ex||5,000||2.00||10,000|
|2006-01-26||Hartman James D (Chief Executive Officer)||Option Ex||30,000||1.75||52,500|
|2006-01-24||Erdmann Michael (Secretary)||Option Ex||5,000||1.50||7,500|
|2006-01-24||Kraus Mark C (Executive VP, COO)||Option Ex||14,375||1.75||25,156|
|2006-01-06||Hartman James D (Chief Executive Officer)||Option Ex||20,530||1.28||26,175|
|2005-05-24||Reed James M (Vice President of Sa)||Buy||1,000||6.48||6,480|
|2005-05-13||Auth Thomas L (Director)||Buy||1,000||5.55||5,550|
|2005-03-31||Auth Thomas L (Director)||Buy||14,000||7.90||110,669|
Insider trading activities including stock purchases, stock sales, and option exercises of NPTH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enpath Medical Inc (symbol NPTH, CIK number 833140) see the Securities and Exchange Commission (SEC) website.